We performed restriction analysis and Southern blotting of the muscle mitochondrial DNA from 34 patients suffering from different myopathies. In 13/21 patients with chronic progressive external ophthalmoplegia the muscle mitochondrial DNA was shown to be heteroplasmic. Further mapping by use of several restriction enzymes yielded large deletions in muscles from 10/13 chronic progressive external ophthalmoplegia patients. Most of the deletions spanned large parts of the mitochondrial genome, leading to loss of mitochondrial genes encoding several subunits of the respiratory chain complexes I (NADH-dehydrogenase), IV (cytochrome c oxidase) and V (ATP-synthetase), as well as of several tRNAs.
Introduction
-jf * r î ty of the resulting diseases can range from only slight The most important function of mitochondria is the and discrete forms to those with a lethal outcome, production of energy in the form of ATP by oxidative The variability of the diseases often renders the difphosphorylation via the respiratory chain. As this is ferential diagnosis difficult. In most congenital or an essential requirement for the survival and health infantile forms of the mitochondrial disorders the of nearly all cells, defects in the energy providing leading symptom is lactic acidosis due to an interrupmachinery of the mitochondrion lead to disease. De-tion of substrate utilisation within the mitochondrion, pending on the number of affected cells, the type of Usually the predilection locus of the disease is the organ and the affected metabolic pathway, the sever-skeletal muscle, leading to a classification of these forms as mitochondrial myopathies. In adult forms, discrete parts of the central nervous system are frequently affected and neuromuscular symptoms are the first indicators. Therefore as an important diagnostic step a muscle biopsy is taken and the tissue is subjected to histological, histochemical, electron microscopical and biochemical investigations.
Recently Holt, Harding & Morgan-Hughes (1) discovered a new diagnostic approach when they found deletions of the mitochondrial DNA (mtDNA) in some patients with mitochondrial myopathies. The five respiratory chain complexes are composed of 69 polypeptide subunits, 13 of them encoded by the mitochondrial genome. Since many metabolic pathways are also located specifically within the mitochondrion, the potential number of defects at different sites within the mitochondrion is very large. Thus a detailed classification of the diseases requires the application of many different methods. On the other hand, the amount of muscle tissue usually obtained by biopsy is very limited. Therefore, in order to increase the probability of defect localisation, an adequate diagnostic strategy is necessary, which takes account of the different diagnostic valencies of the methods used.
Here we describe restriction fragment analysis of muscle biopsies from 34 patients with different myopathies, and the results are compared with the histochemical and biochemical data. In some cases genomic Southern blotting was also performed in cultured fibroblasts from affected patients. In addition, we have developed a scheme for an efficient diagnostic procedure for mitochondrial myopathies, taking into account the work so far reported on mtDNA deletions (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) 38) .
Materials and Methods

Patients
The 34 patients were divided into four groups.
Group 1 (patients 1-5 of tab. 1) consisted of 5 patients suffering from typical Kearns-Sayre syndrome, i.e. chronic progressive external ophthalmoplegia, pigmentary retinopathy, heart block and at least one of the following symptoms: limb weakness, ataxia and/or other neurological symptoms.
Group 2 (patients 6 -21 of tab. 1) consisted of 16 patients with ocular myopathy including ptosis and ophthalmoplegia; most of them had an additional symptom like limb weakness, ataxia and/or peripheral neuropathy.
Group 3 (patients 22 -26 of tab. 1) consisted of 5 patients with histochemically and biochemically defined mitochondrial myopathies; all had lactic acidosis; one had mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (patient 22); 2 had fatal infantile cytochrome c oxidase deficiency (patients 23, 24); one had a combined complex I and IV deficiency (patient 25), and one (patient 26) had muscular carnitine deficiency.
Tab. 1. Clinical data of patients with chronic progressive external ophthalmoplegia (group 1, 2) Patient no. 36  34  30  38  38  34  70  70  42  43  45  23  42  70  46  64   Age of  onset  (a)   13  20  30  17  11   17  21  20  30  12  28  58  55  16  37  18  19  42  68  11  62 Clinical symptoms Chronic Retinitis Heart progressive pigmentosa block external ophthalmoplegia
For all patients of groups 1, 2 and 3, histological examination of skeletal muscle revealed ragged red fibers. (20) , then separated by electrophoresis (8 V/cm for 5 h) on an 8 g/1 agarose gel, stained with 0.1 mg/1 ethidium bromide for 15 min and subjected to Southern blotting.
The mitochondrial DNA probes used for hybridization are described in detail elsewhere (12) .
Results and Discussion
Preliminary Remarks
Besides its nuclear genome the cell contains up to several thousand copies of the mtDNA. The mitochondrial genome is double-stranded and circular, unlike the nuclear DNA, which is linear. The 16569 base pair mtDNA constitutes genes that code for 13 subunits of the respiratory chain complexes, 22 tRNAs and 2 rRNAs (22) . As compared with nuclear DNA, the mitochondrial genome has a highly compact structure consisting almost entirely of coding regions ( fig. 1) , and it uses its own genetic code. It is inherited exclusively from the mother and can segregate during mitotic growth. Mitochondrial DNA shows a high mutation rate, yet encodes highly conserved proteins. Because of these traits, analysis of the mtDNA mutations has yielded new insights into the inheritance and the appearance of some neuromuscular defects (23) . Mitochondrial encephalomyopathies are a clinically heterogenous group of neurological disorders characterized histologically by the "ragged red fibres" in muscle. The clinical features include infantile lactic acidosis, Leigh syndrome, chronic progressive external ophthalmoplegia, exercise-induced myopathy and other multisystem disorders. Affection of the central nervous system causes various symptoms like ataxia, blindness, dementia, seizures and stroke-like episodes. Also other organs (heart, kidney, endocrine system) can be affected (24) .
Histochemically or biochemically characterized defects of different parts of the respiratory chain are found in the majority of patients with mitochondrial myopathy. As about 20% of the patients have affected relatives and maternal transmission is much more frequent than paternal transmission it has been suggested that these disorders may be caused by mutation of the mitochondrial genome. Using genomic Southern analysis, Holt et al. (1) recently published the first description of deletions of the mtDNA in some forms of mitochondrial myopathies. In the meantime their results have been confirmed by other groups, including our own (3 -12) .
Treatment of extracted muscular DNA with restriction endonucleases such as Pvull or BamHl, which have only one recognition site in the chronic progressive external ophthalmoplegia genome, usually linearize the mtDNA, resulting in a single band in Southern blots. A possible interference of "mitochondrial" sequences within the nuclear genome can be obviated by short exposure times for the autoradiography, since only high copy number sequences are observable after short time exposure (4). Thus treatment with "single cutter" restriction enzymes and hybridization with labelled total human mtDNA can yield the following patterns ( fig. 2A fig. 2A, patient 3) .
Results
Restriction analysis
Genomic Southern blotting in 34 patients with different myopathies was performed. When the restriction enzymes, BamHl and Pvull, were used to digest muscular DNA from the 13 patients of group 3 and 4, followed by Southern analysis, a single band of the expected size was found. Thus, there was no mutation involving a lengthy sequence of DNA, i. e. no deletion or insertion, in the muscular mtDNA of these patients. Similarly, no mtDNA deletions were detected in fibroblast cultures from the patients of group 3. DNA samples from all patients of group 3 and 4 were therefore not further investigated. Hybridisation analysis, after digestion with BamHl and Pvull of the muscular DNA from the 21 patients of group 1 and 2, showed in 13/21 a pattern consistent with two mtDNA populations (mtDNA heteroplasmy); one band corresponded to full-length molecules of mtDNA, while the other, more rapidly migrating band corresponded to smaller, deleted mtDNA. This pattern was found in all 5 patients with the typical Kearns-Sayre triad (25) (group 1) and in 8/16 in group 2. The remaining 8 patients of group 2 showed a normal pattern and were therefore excluded from further mapping. We cannot exclude however that there were small deletions or even point mutations in these 8 patients. Ten of the 13 patients of group I and II with mitochondrial heteroplasmy were further mapped, using a set of different restriction enzymes ( fig. 2B) . The site and size of the deletions within the mutated mitochondrial genome are further demonstrated in figure 3 . All deletions affected parts of the genes coding for the subunits of complex I of the respiratory chain, and in 9/10 cases the genes for complex IV and V subunits were also involved. In one case only (patient 4 of tab. 1), the gene for cytochrome b (the only mitochondrially encoded complex III subunit) was also affected. In 8 of the 10 mutated mitochondrial genomes ( fig. 3) 
Histochemistry
A detailed discussion of the extent to which the observed deletions are reflected by histochemical and biochemical measurements in muscle is given elsewhere (12). Here we refer to the diagnostic value of the different methods used. In brief, histochemically we found normal complex II activities in all muscle fibres (not shown in tab. 1), while on the other hand focal deficiency of complex IV was found in all 13 patients with mitochondrial DNA deletions, although in partient 3 (tab. 1) the deletion did not affect mitochondrial complex IV and V genes. Mitochondrial ATP-synthetase was measured histochemically only in 6 out of 13 patients with deleted mitochondrial genomes and was found to be diminished in 4/6. Only 5/7 patients with a mitochondrial DNA deletion spanning at least parts of the three complex IV genes also had a biochemically deficient cytochrome c oxidase activity in their muscle homogenates.
Discussion
Similar results (i. e. no clear cut correlation between site and size of the mtDNA deletions at one site and the loss of biochemically measured enzyme activities as well as the severity of the disease at the other site) have also recently been published by other groups (4, 7, 38). The possible reasons for this lack of a clear correlation are discussed in detail elsewhere (12).
So far, 89 patients with mitochondrial myopathies have been described in the literature (1 -12, 38), whose mitochondrial DNA exhibits lengthy deletions (tab. 2). All of these had chronic progressive external ophthalmoplegia and all had two populations of mtDNA in their muscle mtDNA (heteroplasmy), with the exception of reference (5).
Taking the results reported so far in the literature (tab. 2) together with our present work, the following conclusions can be drawn.
First, lengthy deletions of the mitochondrial genome were found exclusively in patients with chronic progressive external ophthalmoplegia. Out of 52 patients with the typical Kearns-Sayre triad reported so far, 46 had a mitochondrial heteroplasmy and a population of deleted mtDNA. Poulton et al. (8) 
Secondly, no lengthy deletions of the mtDNA have so far been detected by restriction analysis in other defined mitochondrial myopathies or encephalomyopathies, such as myopathies with lactic acidosis, benign or fatal infantile cytochrome c oxidase deficiency, Luffs disease, mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes, myoclonus epilepsy with ragged red fibers (with the exception of 1. c. (5)) and others. Wallace (28) presented considerable evidence for small mtDNA deletions in myoclonus epilepsy with ragged red fibers. A point mutation was observed in cases with Leber's opticus atrophy (29) .
Thirdly, usually a normal pattern for complex II activity was found histochemically in muscles from patients with chronic progressive external ophthalmoplegia, with the exception of 1. c. (30) . Exact histochemical determination of NADH-dehydrogenase is impossible, because the rotenone-sensitive (complex I) and rotenone-insensitive activities (microsomal fraction) cannot be separated by this technique. Focal deficiency of complex IV activity was found in the majority of patients with chronic progressive external ophthalmoplegia, but also in patients suffering from other forms of mitochondrial myopathy, indicating defects in the nuclear-rmtochondrial axis. Histochemical determination of cytochrome c oxidase therefore seems to be a good screening method for all forms of mitochondrial myopathy involving the respiratory chain. ATPase activity was found to be deficient in about 30-50% of the patients with mtDNA deletions.
Fourthly, biochemical measurements of the different complexes of the respiratory chain yielded decreased activity only in 30 -50% of patients with a deleted mitochondrial genome. This is probably due to the fact that in Kearns-Sayre syndrome and related disorders focal defects affecting only single fibres are common. Overall activity measurements in tissue homogenates might therefore not reflect the situation, because the number of affected cells is to small. Biochemical measurements in muscle homogenates from patients with chronic progressive external ophthalmoplegia are therefore of minor diagnostic value.
Fifthly, as can be seen from table 2, in more than 50 percent of patients with chronic progressive external ophthalmoplegia, restriction fragment analysis did not detect any large mtDNA deletions. However this does not necessarily mean that there were no mtDNA mutations in these patients. For methodical reasons detection of mutations by genomic Southern blotting depends on a given length of the mutation (about 200 base pairs) and on a given number of mutated genomes (about 5% of total mtDNA). If neither parameter attains its necessary value, restriction analysis will yield false negative results. A convincing example for this fact was given most recently by Sato et al. (10) . Using a primer shift polymerase chain reaction the authors were able to demonstrate seven populations of differently deleted mtDNA (3.9-5.2 kb in length) in a patient with chronic progressive external ophthalmoplegia. In this patient a normal BamHI and Pvull restriction pattern was found, his isolated muscle mitochondria showed normal activities for all respiratory chain complexes, and the Western blot analysis of several subunits of the respiratory chain complexes yielded a normal pattern. The authors noted that the history of the patient's family suggested maternal transmission of the disease.
Sixthly, the question of whether the large mtDNA deletions found in patients with chronic progressive external ophthalmoplegia are maternally transmitted, 1. e. inherited, or indeed genetic, but aquired during the early state of development is of major importance for genetic counselling. All of our 13 patients with mtDNA deletions were singleton cases, while three patients of group 2 without a mutated mitochondrial genome had affected family members. Out of the 21 chronic progressive external ophthalmoplegia patients with mtDNA heteroplasmy reported by Holt et al. (1, 2, 38) only two had a similarly affected relative, while 10 of their patients without deletions had clinically affected family members, and maternal transmission occurred in 50%. None of the 32 chronic progressive external ophthalmoplegia cases with mtDNA deletion described by Moreas et al. (7) had affected family members, whereas approximately half (13/27) the patients with ocular myopathy but without detectable mtDNA deletions had. Thus it seems evident that the majority of chronic progressive external ophthalmoplegia patients with mtDNA deletions detectable by restriction analysis and Southern botting are spontaneous singleton cases. There are three reports (4, 10, 31) dealing with inheritance of larger mtDNA deletions. Ozawa et al. (4) described maternal inheritance of non-identical mtDNA deletions in a mother/daughter pair. The same group reported (10) the case mentioned above with deletions only demonstrable after amplification of the mitochondrial genome using the polymerase chain reaction. Zeviani et al. (31) in a most recent paper demonstrated an autosomal dominant disorder with multiple deletions of mtDNA in a large Italian family suffering from late-onset mitochondrial myopathy, including chronic progressive external ophthalmoplegia, progressive proximal weakness, bilateral cataract and precocious death. This report demonstrated in an impressive way the close cooperation between the nuclear genome and the mtDNA in order to establish the highly organized structure of the respiratory chain complexes.
As Kearns-Sayre syndrome and related diseases are multisystem disorders the mtDNA deletions may not be confined to skeletal muscle alone, but may affect other tissues. Similar deletions to those in muscle have been found in single cases in brain, liver, spinal cord, primary fibroblasts and myoblast cultures as well as in white blood cells (9, 11, 32, 33) . While we were able to detect an identical deletion, i. e. of equal size and site, in skeletal muscle, heart, liver and kidney in one Kearns-Sayre patient (34), we could find no corresponding mutations in fibroblast cultures or in white blood cells from two others. Holt et al. (1, 2, 38) were also unable to find deletions in the mtDNA of leukocytes from their patients with deleted muscular mitochondrial genome. This discrepancy or uneven distribution of affected mitochondrial genomes in different tissues might be due to mitotic segregation (23) during the early state of development of the oocyte or the zygote, resulting in quite different proportions of deleted genomes in the different tissues. Furthermore, the method of restriction analysis might not be sensitive enough to detect small proportions of deleted mtDNA. Amplification of the "hot spot" regions within the mitochondrial genome by the polymerase chain reaction (26, 27, 35) will probably solve the question of whether white blood cells or fibroblasts could serve for diagnosis.
Diagnostic procedures
With respect to the limited tissue material usually available and taking into consideration the data in the literature, we propose the diagnostic procedure given in figure 4 . The main conclusions regarding the choice of diagnostic procedure are set out below. *) including: myoclonus epilepsy with ragged red fibres, mitochondrial encephalomyopathy/lactic acidosis/stroke, Leigh syndrome, congenital lactic acidosis, benign and fatal cytochrome c oxidase deficiency, ATPase deficiency and other diseases without chronic progressive external ophthalmoplegia -For exact defect localization, restriction analysis and mapping of muscular mtDNA is superior to histological, histochemical and biochemical methods in patients with chronic progressive external ophthalmoplegia. The latter methods provide confirmatory evidence. In chronic progressive external ophthalmoplegia cases with a family history of the disease, if the restriction analysis using single cutter restriction endonucleases gives a negative result, the mitochondrial genome fragments should be amplified by the polymerase chain reaction. The same is true for other mitochondrial disorders with maternal transmission, where restriction analysis of the mtDNA so far failed to detect any mutations. DNA techniques, which allow the detection of small or even point mutations have been successfully applied in cases with Leber's opticus atrophy (29) , and these should also be used for other patients.
-Histological, histochemical, immunological and biochemical determinations are the methods of choice for the time being for all spontaneous singleton cases suffering from mitochondrial myopathies with lactic acidosis as the leading symptom, since DNA techniques at the level of the nuclear genome are still in their infancy. With respect to the tissue specificity of certain mitochondrial diseases, the existence and the investigation of nuclear encoded isoforms, for example of cytochrome c oxidase (36), will be of special interest.
A closer cooperation between clinicians, biochemists and molecular biologists is necessary in the near future, in order to develop successful diagnostic procedures for the different forms of mitochondrial disorders. As noted by Wallace (87), a wide spectrum of neuromuscular diseases has been shown to be influenced by maternal factors. DNA techniques will undoubtedly soon identify other mtDNA genetic diseases, ultimately replace biochemical and histochemical procedures and lead to a better understanding of the underlying principles of genetic mitochondrial disorders.
